CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Clearside Biomedical, Inc. - CLSD CFD

1.2172
9.65%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0156
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 1.3472
Open 1.3472
1-Year Change 58.05%
Day's Range 1.2072 - 1.3672
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 13, 2024 1.2172 -0.1400 -10.32% 1.3572 1.3672 1.1872
Sep 12, 2024 1.3472 0.0900 7.16% 1.2572 1.3672 1.2572
Sep 11, 2024 1.2972 0.1800 16.11% 1.1172 1.2972 1.1172
Sep 10, 2024 1.1267 0.0600 5.62% 1.0667 1.1267 1.0567
Sep 9, 2024 1.0567 0.0610 6.13% 0.9957 1.0967 0.9957
Sep 6, 2024 0.9570 0.0160 1.70% 0.9410 0.9751 0.9409
Sep 5, 2024 0.9241 -0.0326 -3.41% 0.9567 0.9567 0.9167
Sep 4, 2024 0.9622 -0.0246 -2.49% 0.9868 0.9957 0.9567
Sep 3, 2024 0.9917 -0.0150 -1.49% 1.0067 1.0067 0.9867
Aug 30, 2024 1.0067 0.0100 1.00% 0.9967 1.0067 0.9967
Aug 29, 2024 0.9967 0.0000 0.00% 0.9967 0.9967 0.9580
Aug 28, 2024 0.9867 -0.0300 -2.95% 1.0167 1.0167 0.9667
Aug 27, 2024 0.9967 -0.0300 -2.92% 1.0267 1.0367 0.9967
Aug 26, 2024 0.9967 -0.0300 -2.92% 1.0267 1.0267 0.9967
Aug 23, 2024 1.0067 0.0100 1.00% 0.9967 1.0167 0.9867
Aug 22, 2024 0.9967 -0.0100 -0.99% 1.0067 1.0267 0.9967
Aug 21, 2024 1.0067 -0.0200 -1.95% 1.0267 1.0367 0.9967
Aug 20, 2024 0.9967 0.0000 0.00% 0.9967 1.0167 0.9868
Aug 19, 2024 1.0067 -0.0200 -1.95% 1.0267 1.0367 0.9767
Aug 16, 2024 1.0067 -0.0300 -2.89% 1.0367 1.0567 0.9717

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Clearside Biomedical, Inc. Company profile

About Clearside Biomedical Inc

Clearside Biomedical, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Its proprietary suprachoroidal space (SCS) microinjector targeting SCS offers access to the macula, retina and choroid where sight-threatening disease often occurs. The SCS injection platform is an inherently flexible, in-office, non-surgical procedure intended to provide targeted delivery to the site of disease and to work with both established and new formulations of medications, as well as future therapeutic innovations. The Company’s suprachoroidal injection platform is a patented approach for delivering pharmacotherapy to the back of the eye through SCS. The Company’s lead product candidate, XIPERE, is a preservative-free suspension of the corticosteroid triamcinolone acetonide (TA), formulated for administration through suprachoroidal injection.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Clearside Biomedical Inc revenues increased from $7.9M to $29.6M. Net income totaled $376K vs. loss of $18.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Other expense decrease from $275K (expense) to $0K. Basic Earnings per Share excluding Extraordinary Items increased from -$0.39 to $0.01.

Industry: Bio Therapeutic Drugs

900 North Point Parkway
Suite 200
ALPHARETTA
GEORGIA 30005
US

News

ECB Preview: cuts expected but the pace is uncertain

Markets expect the ECB to cut rates again in September, but how many more?

12:34, 11 September 2024

Market analysis: US CPI and PPI

Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.

07:56, 10 September 2024

Introducing Newsquawk: your new in-platform newsfeed

We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.

14:09, 20 August 2024

Jackson Hole Preview: All eyes on Powell and Gold

The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.

15:24, 19 August 2024

All eyes on inflation: US and UK CPI take centre stage

Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.

14:41, 13 August 2024

European stocks face resistance in their attempt to recover

European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.

13:56, 9 August 2024

Global selloff continues on US economy fears

Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.

14:40, 5 August 2024

People also watch

US100

19,488.30 Price
+0.520% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

Gold

2,579.30 Price
+0.780% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0109%
Overnight fee time 21:00 (UTC)
Spread 0.60

XRP/USD

0.59 Price
-1.460% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Oil - Crude

68.51 Price
-0.040% 1D Chg, %
Long position overnight fee 0.0336%
Short position overnight fee -0.0555%
Overnight fee time 21:00 (UTC)
Spread 0.030

Still looking for a broker you can trust?

Join the 640,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading